Sonova appoints Vice President Sales Asia Pacific

Media Release

Sonova appoints Vice President Sales Asia Pacific

Staefa (Switzerland), 12.02.2013 - Sonova Holding AG, the world's leading
provider of hearing solutions, announces today the appointment of Chin-Hwee
Lim to the position of Vice President Sales Asia Pacific. After a short
transition period, the Singapore citizen will be responsible for Sonova's
hearing instrument business in the region and join Sonova's Management Board,
effective 1 April 2013.Based in Singapore, Lim will report directly to Lukas
Braunschweiler, CEO of Sonova Holding AG.

Asia-Pacific represents a great opportunity for future growth for Sonova.
Creating this new position further strengthens Sonova's ongoing commitment to
the region and its importance to its business growth strategy. "Chin-Hwee's
wealth of experience in healthcare and success in driving growth in emerging
markets combined with his passion and ability to build and lead
high-performing teams, make him the ideal choice to lead Sonova towards the
next phase of sustainable growth in the region," said Lukas Braunschweiler,
CEO of Sonova.

Chin-Hwee Lim joins Sonova from Medtronic, China, where under his leadership
the company has seen significant growth. Previous professional experience
include senior positions at Novartis, Merck Sharp & Dohme and Abbott. Lim
holds a Bachelor of Engineering in Chemical Engineering from the National
University of Singapore.

In addition to Lim, the company will expand its Management Board, reflecting
the significance of Sonova's growth strategy across all businesses. With
effect from 1 April 2013, Stefan Launer (Vice President Science & Technology),
Jan Metzdorff (Vice President Unitron) and Franz Petermann (Vice President
Channel Solutions) will join the Management Board. To date all three new
members have already successfully worked in their current role at Sonova. "By
creating the new position for the Asia-Pacific region and enhancing our
organizational structure, Sonova is ideally positioned for the future", adds

- End -

                       Thomas Bernhardsgruetter

                       Investor Relations

                       Phone +41 58 928 33 44

                       Mobile +41 79 618 28 07


                       Nicole Mueller

Contacts               Investor Relations

                       Phone +41 58 928 33 22

                       Michael Isaac

                       Media Relations

                       Phone +41 58 928 33 24

                       Mobile +41 79 420 29 56



This Media Release contains forward-looking statements, which offer no
guarantee with regard to future performance. These statements are made on the
basis of management's views and assumptions regarding future events and
business performance at the time the statements are made. They are subject to
risks and uncertainties including, but not confined to, future global economic
conditions, exchange rates, legal provisions, market conditions, activities by
competitors and other factors outside Sonova's control. Should one or more of
these risks or uncertainties materialize or should underlying assumptions
prove incorrect, actual outcomes may vary materially from those forecasted or
expected. Each forward-looking statement speaks only as of the date of the
particular statement, and Sonova undertakes no obligation to publicly update
or revise any forward-looking statements, except as required by law.

About Sonova

Sonova Holding AG, headquartered in Staefa, Switzerland, is the leading
manufacturer of innovative hearing care solutions. The group operates through
its core business brands Phonak, Unitron, Advanced Bionics and Connect
Hearing. Sonova offers its customers one of the most comprehensive product
portfolios in the industry - from hearing instruments to cochlear implants to
wireless communication solutions. Founded in 1947, the group is currently
present in over 90 countries across the globe and has a workforce of over
8,500 dedicated employees. Sonova generated sales of CHF 1,62 billion in the
financial year 2011/12 and a net profit of CHF 246 million. By supporting the
Hear the World Foundation, Sonova pursues its vision of a world where everyone
enjoys the delight of hearing and therefore lives a life without limitations.

For more information please visit and

Sonova shares (ticker symbol:SOON, Security no: 1254978, ISIN: CH1012549785)
have been listed on the SIX Swiss Exchange since 1994. The securities of
Sonova have not been and will not be registered under the U.S. Securities Act
of 1933, as amended (the "U.S. Securities Act"), or under the applicable
securities laws of any state of the United States of America, and may not be
offered or sold in the United States of America except pursuant to an
exemption from the registration requirements under the U.S. Securities Act and
in compliance with applicable state securities laws, or outside the United
States of America to non-U.S. Persons in reliance on Regulation S under the
U.S. Securities Act.

Media Release (PDF)

Provider                  Channel         Contact
Tensid Ltd., Switzerland      Provider/Channel related enquiries   
                                          +41 41 763 00 50
Press spacebar to pause and continue. Press esc to stop.